| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former 10% Owner | 10% Owner
3 companies
Column Group Ii, LP is a 10% Owner at RCUS with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 20 sells.
Estimated insider holdings value: $53.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2021 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Sell | 95,746 | $31.30 | $2,996,515.88 | -13.0% | +3.4% | -8.0% | |
| Sep 22, 2020 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Sell | 608,000 | $30.85 | $18,756,800.00 | -13.7% | - | - | |
| Aug 17, 2020 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Sell | 538,654 | $22.75 | $12,254,378.50 | -10.8% | - | - | |
| Nov 4, 2019 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Buy | 625,000 | $12.00 | $7,500,000.00 | +14.3% | - | - |